Ignite Creation Date:
2025-12-25 @ 3:13 AM
Ignite Modification Date:
2026-03-01 @ 6:02 AM
Study NCT ID:
NCT02429505
Status:
WITHDRAWN
Last Update Posted:
2020-08-28
First Post:
2015-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
Sponsor:
Knight Therapeutics (USA) Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-22
First Submit QC Date:
None
Study First Post Date:
2015-04-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-26
Last Update Post Date:
2020-08-28
Last Update Post Date Type:
ACTUAL